Bentham Science Logo


S.No. Title Source Title Authors DOI Citing Works Count
1 Human Imprinting Anomalies in Fetal and Childhood Growth Disorders: Clinical Implications and Molecular Mechanisms Current Pharmaceutical Design Salah Azzi; Frédéric Brioude; Yves Le Bouc; Irène Netchine 10.2174/13816128113199990525 8
2 Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease. Current Alzheimer Research Laure Rouch; Philippe Cestac; Charlène Cool; Catherine Helmer; Jean-François Dartigues; Claudine Berr; Olivier Rouaud; Bruno Vellas; Sandrine Andrieu 1
3 Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context. Current Stem Cell Research & Therapy Loïc Reppel; Talar Margossian; Layale Yaghi; Philippe Moreau; Nathalie Mercier; Léonore Leger; Sébastien Hupont; Jean-François Stoltz; Danièle Bensoussan; Céline Huselstein 10.2174/1574888x09666140213204850 21
4 Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome. CNS & Neurological Disorders Drug Targets Marie-Claude Potier; Jérôme Braudeau; Luce Dauphinot; Benoît Delatour 10.2174/18715273113126660185 19
5 The "Methyl-CpG Binding Domain protein 2" plays a repressive role in relation to the promoter CpG content in the normal human cell line MRC5. Current Pharmaceutical Design Laury Perriaud; Joël Lachuer; Robert Dante 10.2174/13816128113199990537 1
6 Editorial (Thematic Issue: New Behaviors, New Drugs: The Modern Landscape of Addiction) Current Pharmaceutical Design Laurent Karila 10.2174/13816128113199990627 0
7 Protease-Activated Receptors as Therapeutic Targets in Visceral Pain Current Neuropharmacology Nicolas Cenac 10.2174/1570159x113119990039 21
8 Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction Cardiovascular & Hematological Agents In Medicinal Chemistry Ousama Dayoub; Ramaroson Andriantsitohaina; Nicolas Clere 10.2174/1871525712666140309233048 16
9 Indocyanine green: photosensitizer or chromophore? Still a debate Current Medicinal Chemistry Camille Giraudeau; Albert Moussaron; Aurélie Stallivieri; Serge Mordon; Céline Frochot 10.2174/0929867321666131218095802 43
10 Specificities of the diabetic population in French Guiana: The health barometer survey. Current Diabetes Reviews Nadia Sabbah; Mickael Massicard; Nacher Mathieu 10.2174/1573399817666210129103506 0
11 Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer's Disease Patients. Current Alzheimer Research Amira Zarrouk; Souha Hammouda; Imen Ghzaiel; Sonia Hammami; Wided Khamlaoui; Samia Hadj Ahmed; Gérard Lizard; Mohamed Hammami 10.2174/1567205017666201203123046 0
12 New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases. Current Drug Targets Laura Loy; Gionata Fiorino; Giulia Roda; Mariangela Allocca; Federica Furfaro; Alessandra Zilli; Daniela Gilardi; Simona Radice; Laurent Peyrin-Biroulet; Silvio Danese 10.2174/1389450121666201211162527 0
13 Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? Current Drug Targets Roberto Gabbiadini; Eirini Zacharopoulou; Federica Furfaro; Vincenzo Craviotto; Alessandra Zilli; Daniela Gilardi; Giulia Roda; Laura Loy; Gionata Fiorino; Laurent Peyrin-Biroulet; Silvio Danese; Mariangela Allocca 0
14 Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg Current Protein & Peptide Science Valentina Lukinović; Alexandre G. Casanova; Gaël S. Roth; Florent Chuffart; Nicolas Reynoird 10.2174/1871527319666200102101608 0
15 Human Exfoliated Deciduous Teeth Stem Cells: Features and Therapeutic Effects on Neurogenerative and Hepatobiliary-Pancreatic Diseases. Current Stem Cell Research & Therapy Nurul Wahidah Abdul Wahab; Rhanye Mac Guad; Vetriselvan Subramaniyan; Ismail M. Fareez; Ker Woon Choy; Srinivasa Reddy Bonam; Chandrasekaran Selvaraju; Maw Shin Sim; Subash C. B. Gopinath; Yuan Seng Wu 10.2174/1574888x15999200918105623 0
16 Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured Carotids. Current Vascular Pharmacology Eléonore M'Baya-Moutoula; Alexandre Marchand; Isabelle Six; Noura Bahrar; Tanja Ćelić; Nathalie Mougenot; Pierre Maitrias; Ziad A. Massy; Anne-Marie Lompré; Laurent Metzinger; Valérie Metzinger-Le Meuth 10.2174/1570161117666190705141152 6
17 Insights into Biophysical Methods to Study Interactions Between HIV-1 Reverse Transcriptase and Non-nucleoside Reverse Transcriptase Inhibitors Letters In Drug Design & Discovery Julien Dumond; Jean-Marcel Julien Tronchet; Serge Kirkiacharian; Michel Seman; Michèle Reboud-Ravaux 10.2174/1570180816666190723121845 0
18 The Experimentally Obtained Functional Impact Assessments of 5' Splice Site GT'GC Variants Differ Markedly from Those Predicted. Current Genomics Jian-Min Chen; Jin-Huan Lin; Emmanuelle Masson; Zhuan Liao; Claude Férec; David Neil Cooper; Matthew Hayden 10.2174/1389202921666200210141701 3
19 Resistant Hypertension: Novel Insights. Current Hypertension Reviews Guillaume Lamirault; Mathieu Artifoni; Mélanie Daniel; Nicolas Barber-Chamoux 10.2174/1573402115666191011111402 1
20 Common Pathological Mechanisms and Risk Factors for Alzheimer's Disease and Type-2 Diabetes: Focus on Inflammation. Current Alzheimer Research Emmanuel Moyse; Mohamed Haddad; Camelia Benlabiod; Charles Ramassamy; Slavica Krantic 10.2174/1567205016666191106094356 3
21 New Copper Compounds with Antiplatelet Aggregation Activity. Medicinal Chemistry (Shariqah (United Arab Emirates)) Mirthala Flores-García; Juan M. Fernández-G; Cristina Busqueta-Griera; Elizabeth Gómez; Simón Hernández-Ortega; Jean Christian Daniel Lamothe-Flores; Virginia Gómez-Vidales; Ana María Mejía-Dom&iacut 10.2174/1573406415666190222123207 0
22 Impact of Collateral Status on Neuroprotective Effect of Cyclosporine A in Acute Ischemic Stroke. Current Neurovascular Research Norbert Nighoghossian; Lucie Cornut; Camille Amaz; Omer Eker; Nathan Mewton; Roxana Ameli; Lise Prune Berner; T.-H. Cho; Michel Ovize; Yves Berthezène 10.2174/1567202616666190618094014 0
23 Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease? Current Pharmaceutical Design Marjorie Argollo; Mariangela Allocca; Federica Furfaro; Laurent Peyrin-Biroulet; Silvio Danese 10.2174/1381612825666190313140811 4
24 Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference? Current Pharmaceutical Design Ferdinando D'Amico; Giulia Roda; Laurent Peyrin-Biroulet; Silvio Danese 10.2174/1381612825666190307165703 2
25 Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time? Current Pharmaceutical Design Marjorie Argollo; Daniela Gilardi; Giulia Roda; Gionata Fiorino; Laurent Peyrin-Biroulet; Silvio Danese 10.2174/1381612825666190308100844 2
26 Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that? Current Pharmaceutical Design Marjorie Argollo; Gionata Fiorino; Daniela Gilardi; Federica Furfaro; Giulia Roda; Laura Loy; Mariangela Allocca; Laurent Peyrin-Biroulet; Silvio Danese 10.2174/1381612825666190312113610 5
27 Bacterial Protein Mimetic of Peptide Hormone as a New Class of Protein- based Drugs Current Medicinal Chemistry Sergueï O. Fetissov; Romain Legrand; Nicolas Lucas 10.2174/0929867324666171005110620 9
28 Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level. Current Radiopharmaceuticals Ingrid Kreimerman; Erick Mora-Ramirez; Laura Reyes; Manuel Bardiès; Eduardo Savio; Henry Engler 10.2174/1874471011666180830145304 0
29 Neuroprotection with the Endozepine Octadecaneuropeptide, ODN. Current Pharmaceutical Design Olfa Masmoudi-Kouki; Yosra Hamdi; Ikram Ghouili; Seyma Bahdoudi; Hadhemi Kaddour; Jérôme Leprince; Hélène Castel; Hubert Vaudry; Mohamed Amri; David Vaudry; Marie-Christine Tonon 10.2174/1381612824666181112111746 5
30 Seven Novel and Three Known Mutations in FOXL2 in 10 Chinese Families with Blepharophimosis Syndrome. Current Molecular Medicine B Lin; Binghui Zeng; J Zhao; Tingting Xu; Ye Wang; Bin Hu; Fucheng Li; Qiang Zhao; Ruihong Liu; Jinsong Liu; Jian-Min Chen; D Huang 10.2174/1566524018666180907162619 0
31 Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers. Current Alzheimer Research Olivier Vercruysse; Claire Paquet; Audrey Gabelle; Xavier Delbeuck; Frédéric Blanc; David Wallon; Julien Dumurgier; Eloi Magnin; Olivier Martinaud; Barbara Jung; Olivier Bousiges; Sylvain Lehmann; Constance Delaby; Muriel Quillard-Murain; Ka 10.2174/1567205015666180110113238 3
32 Biologic therapies in ulcerative colitis: primi inter pares? Current Drug Targets Mariangela Allocca; Gionata Fiorino; Daniela Gilardi; Paoletta Preatoni; Alfredo Papa; Laurent Peyrin-Biroulet; Silvio Danese 10.2174/1389450117666160527142719 1
33 Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines. Medicinal Chemistry (Shariqah (United Arab Emirates)) Alexia Jonet; Jean Guillon; Catherine Mullié; Anita Cohen; Guillaume Bentzinger; Jeremy Schneider; Nicolas Taudon; Sébastien Hutter; Nadine Azas; Stéphane Moreau; Solène Savrimoutou; Patrice Agnamey; Alexandra Dassonville-Klimp 10.2174/1573406413666170726123938 7
34 Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities. Current Molecular Medicine Marius Ilie; Jonathan Benzaquen; Véronique Hofman; Sandra Lassalle; Nathalie Yazbeck; Sylvie Leroy; Simon Heeke; Coraline Bence; Baharia Mograbi; Nicolas Glaichenhaus; C.-H. Marquette; Paul Hofman 10.2174/1566524018666180222114038 11
35 The Role of Cannabinoid Receptors in Renal Diseases. Current Medicinal Chemistry Hélène François; Lola Lecru 10.2174/0929867324666170911170020 9
36 Lipid Biomarkers in Alzheimer's Disease Current Alzheimer Research Amira Zarrouk; Meryam Debbabi; Maryem Bezine; El Mostafa Karym; Asmaa Badreddine; Olivier Rouaud; Thibault Moreau; Mustapha Cherkaoui-Malki; Mohamed El Ayeb; Boubker Nasser; Mohamed Hammami; Gérard Lizard 10.2174/1567205014666170505101426 52
37 Experimental Treatment Options in Absence Epilepsy. Current Pharmaceutical Design Gilles van Luijtelaar; Mehrnoush Zobeiri; Annika Lüttjohann; Antoine Depaulis 10.2174/1381612823666171017170226 5
38 Impact of Cone Beam Computed Tomography Dose in Pre-Surgical Implant Analysis The Open Dentistry Journal Nabil El Sahili; Ibrahim Nasseh; Antoine Berberi; Sandra David-Tchouda; Sophie Thoret; Thomas Fortin 10.2174/1874210601812010094 1
39 Early Vascular Ageing (EVA): Definitions and Clinical Applicability Current Hypertension Reviews Pedro Cunha; Pierre Boutouyrie; Peter M. Nilsson; Stéphane Laurent 10.2174/1573402113666170413094319 30
40 Convexity Subarachnoid Hemorrhage, Pseudomonas Aeruginosa (PA) Infective Endocarditis and Left Atrial Appendage Occluder (LAAO) Device Infection. A Case Report. The Open Neuroimaging Journal Monique Boukobza; Ibtissem Smaali; Xavier Duval; Jean-Pierre Laissy 10.2174/1874440001711010026 2
41 HDL-Targeting Therapeutics: Past, Present and Future. Current Pharmaceutical Design Emile Zakiev; Ma Feng; Vasily N. Sukhorukov; Anatol Kontush 10.2174/1381612822666161027153140 7
42 Use of Primary Macrophages for Searching Novel Immunocorrectors Current Pharmaceutical Design Nikita G. Nikiforov; Natalia V. Elizova; Michael Bukrinsky; Larisa Dubrovsky; Vsevolod J. Makeev; Yoshiyuki Wakabayashi; Poching Liu; Kathy K. Foxx; Howard S. Kruth; Xueting Jin; Emile Zakiev; Alexander N. Orekhov 10.2174/1381612823666170125110128 1
43 Melatonin: Pharmacology, Functions and Therapeutic Benefits. Current Neuropharmacology Sylvie Tordjman; Sylvie Chokron; Richard Delorme; Annaëlle Charrier; Eric Bellissant; Nemat Jaafari; Claire Fougerou 10.2174/1570159x14666161228122115 157
44 In vitro Vasorelaxant Effect of Artemisia herba alba Asso. in Spontaneously Hypertensive Rats Cardiovascular & Hematological Agents In Medicinal Chemistry Zeggwagh Naoufel; Morad Hebi; Mohammed Ajebli; J. Michel; Mohamed Eddouks 10.2174/1871525714666161216100044 0
45 Genetic Imbalance in Patients with Cervical Artery Dissection. Current Genomics Caspar Grond-Ginsbach; Bowang Chen; Michael Krawczak; Rastislav Pjontek; Philip Ginsbach; Yanxiang Jiang; Sherine Abboud; M. Arnold; Anna Bersano; Tobias Brandt; Valeria Caso; Stéphanie Debette; Martin Dichgans; Andreas Geschwendtner; Giacomo Giaca 10.2174/1389202917666160805152627 15
46 Genetic Influences in Cannabis Use Disorder and Psychosis: Dopamine and Beyond. Current Pharmaceutical Design Amine Benyamina; Laurent Karila; Geneviève Lafaye; Lisa Blecha 10.2174/1381612822666160831095707 6
47 The mir-221/222 Cluster is a Key Player in Vascular Biology via the Fine-Tuning of Endothelial Cell Physiology Current Vascular Pharmacology Tanja Ćelić; Valérie Metzinger-Le Meuth; Isabelle Six; Ziad A. Massy; Laurent Metzinger 10.2174/1570161114666160914175149 25
48 Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers. Recent Patents On Anti-cancer Drug Discovery Amélie Fouqué; Mickael Jean; Pierre Van de Weghe; Patrick Legembre 10.2174/1574892811666160519113731 21
49 Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia. The Open Neurology Journal J. Cogez; Olivier Etard; Nathalie Derache; Gilles Defer 10.2174/1874205x01610010009 2
50 AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives Current Drug Targets Claudia Marinangeli; Sébastien Didier; Valérie Vingtdeux 10.2174/1389450117666160201105645 21
51 Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets. Current Pharmaceutical Design Marie Levade; Sonia Severin; Marie-Pierre Gratacap; Loic Ysebaert; Bernard Payrastre 10.2174/1381612822666160226132630 12
52 Vaccination and Induction of Autoimmune Diseases Inflammation & Allergy Drug Targets Eric Toussirot; Matthieu Béreau 10.2174/1871528114666160105113046 14
53 Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways Current Gene Therapy P. Resnier; Angélique Mottais; Yann Sibiril; T. Le Gall; Tristan Montier 10.2174/1566523216666160104142013 7
54 "My Life Needs Editing" (Mort Sahl) and Genome Editing Needs Ethics. Current Gene Therapy Ignacio Anegon; Tuan H. Nguyen 10.2174/1566523216999160128110659 2
55 Natural and Induced Antibody Polyreactivity. Anti-cancer Agents In Medicinal Chemistry Annaelle Jarossay; Maya Hadzhieva; Srinivas V. Kaveri; Sébastien Lacroix-Desmazes; Jordan D. Dimitrov 10.2174/1871520615666150716104935 4
56 Autophagy : Moving Benchside Promises to Patient Bedsides. Current Cancer Drug Targets Amine Belaid; Papa Diogop Ndiaye; Harilaos Filippakis; Jérémie Roux; Eric Rottinger; Yacine Graba; Patrick Brest; Paul Hofman; Baharia Mograbi 10.2174/156800961508151001102452 11
57 Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm. Current Pharmaceutical Design Stephane Potteaux; Alain Tedgui 10.2174/1381612821666150826093855 16
58 Why Anticancer Nanomedicine Needs Sugars Current Medicinal Chemistry Elise Bouffard; K. El Cheikh; Audrey Gallud; A. B. F. da Silva; Marie Maynadier; Ilaria Basile; Magali Gary-Bobo; Alain Morere; M. Garcia 10.2174/0929867322666150805103104 3
59 ACE Inhibitor Delapril Prevents Ca(2+)-Dependent Blunting of IK1 and Ventricular Arrhythmia in Ischemic Heart Disease. Current Molecular Medicine Jérôme Thireau; Santiago Zalvidea; Pieere Meschin; Jean-Luc Pasquié; Franck Aimond; Sylvain Richard 10.2174/1566524015666150831131459 6
60 Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls Current Gene Therapy Delphine Trochet; Bernard Prudhon; Stéphane Vassilopoulos; Marc Bitoun 10.2174/1566523215666150812115730 11
61 Off-label treatments for mental health: inappropriate or unavoidable? a special issue to help get through the maze Current Pharmaceutical Design Benjamin Rolland; Ali Amad 10.2174/138161282123150723153610 1
62 Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression. Current Topics In Medicinal Chemistry Mohamed Amine Bouhlel; Mélanie Lambert; Marie-Hélène David-Cordonnier 10.2174/1568026615666150413154713 27
63 Synthetic Cathinones: A New Public Health Problem Current Neuropharmacology Laurent Karila; Bruno Mégarbane; Olivier Cottencin; Michel Lejoyeux 10.2174/1570159x13666141210224137 160
64 Novel synthetic pharmacophores inducing a stabilization of cellular microtubules. Current Cancer Drug Targets Anne Martinez; Emmanuelle Soleilhac; Caroline Barette; Renaud Prudent; Gustavo Jabor Gozzi; Emilie Vassal-Stermann; Catherine Pillet; Attilio Di Pietro; Marie-Odile Fauvarque; Laurence Lafanechère 10.2174/1568009615666141215154149 3
65 Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies. Current Pharmaceutical Biotechnology null Aires; Dominique Delmas 10.2174/1389201016666150118132457 15
66 Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease Current Gene Therapy Olivier Negre; Cynthia C. Bartholomae; Yves Beuzard; Marina Cavazzana; Lauryn Christiansen; Celine Courne; Annette Deichmann; Maria Denaro; Edouard de Dreuzy; Mitchell Finer; Raffaele Fronza; Beatrix Gillet-Legrand; Christophe Joubert; Robert H. Kutner; P 10.2174/1566523214666141127095336 62
67 Novel strategies for preventing diabetes and obesity complications with natural polyphenols. Current Medicinal Chemistry Christian Carpéné; Saioa Gómez-Zorita; S. Deleruyelle; M.A. Carpene 10.2174/0929867321666140815124052 34
68 Codon Swapping of Zinc Finger Nucleases Confers Expression in Primary Cells and In Vivo from a Single Lentiviral Vector Current Gene Therapy Cecilia Abarrategui-Pontes; Alison Creneguy; Reynald Thinard; Eli J. Fine; Virginie Thepenier; Laure Fournier Le Ray; Thomas J. Cradick; Gang Bao; Laurent Tesson; Guillaume Podevin; Ignacio Anegon; Tuan Huy Nguyen 10.2174/156652321405140926161748 7
69 A suicide gene therapy combining the improvement of cyclophosphamide tumor cytotoxicity and the development of an anti-tumor immune response. Current Gene Therapy Walid Touati; Thi Anh-Dao Tran; Johanne Seguin; Monique Diry; Jean-Pierre Flinois; Claude Baillou; Géraldine Lescaille; François André; Eric Tartour; François M. Lemoine; Philippe Beaune; Isabelle de Waziers 10.2174/1566523214666140424152734 12
70 Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction. Current Pharmaceutical Biotechnology Jin B Su 10.2174/1389201015666140515143624 2
71 Structure and function of MPN (Mpr1/Pad1 N-terminal) domain-containing proteins. Current Protein & Peptide Science Melissa Birol; Aude Echalier 10.2174/1389203715666140221095109 15
72 Metabolic features of melanoma: a gold mine of new therapeutic targets? Current Cancer Drug Targets Philippe Marchetti; Pierre Guerreschi; Jerome Kluza; Laurent Mortier 10.2174/1568009614666140407113124 7
73 The risk of progressive multifocal leukoencephalopathy under biological agents used in the treatment of chronic inflammatory diseases. Inflammation & Allergy Drug Targets Eric Toussirot; Matthieu Bereau 10.2174/1871528113666140224103712 19
74 Preface: In 2013 gene therapy is a Nike; for 2014, just do it! Current Gene Therapy Ignacio Anegon 10.2174/156652321402140318170226 2
75 Connexins in renal endothelial function and dysfunction. Cardiovascular & Hematological Disorders Drug Targets Ahmed Abed; Jean-Claude Dussaule; Jean-Jacques Boffa; Christos Chatziantoniou; Christos E. Chadjichristos 10.2174/1871529x14666140401105827 9
76 Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration. Current Pharmaceutical Design Catarina Chaves; Ramzi Shawahna; Aude Jacob; Jean-Michel Scherrmann; Xavier Declèves 10.2174/13816128113199990466 25
77 Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Current Pharmaceutical Design Jean Bousquet; Christian Jorgensen; Michel Dauzat; Alfredo Cesario; Thierry Camuzat; Rodolphe Bourret; Nicolas Best; Josep M. Antó; Frédéric Abecassis; Pierre Aubas; A. Avignon; Mélanie Badin; Anna Bedbrook; Hubert Blain; Arnau 10.2174/1381612820666140314115505 52
78 Chemical metabolic inhibitors for the treatment of blood-borne cancers. Anti-cancer Agents In Medicinal Chemistry Martin Villalba; Nuria Lopez-Royuela; Ewelina Krzywinska; Moeez Ghani Rathore; Robert A. Hipskind; Houda Haouas; Nerea Allende-Vega 10.2174/18715206113136660374 21
79 Quantifying Gp96/Grp94 complexes preparations for vaccines: a key step often inaccurate. Current Medicinal Chemistry A. Seignez; Evelyne Kohli; Carmen Garrido; Renaud Seigneuric 10.2174/09298673113206660304 0
80 Janus Kinase Inhibition with Tofacitinib: Changing the Face of Inflammatory Bowel Disease Treatment Current Drug Targets Lucine Vuitton; Stéphane Koch; Laurent Peyrin-Biroulet 10.2174/13894501113149990160 32
81 Therapeutic perspectives for cN-II in cancer. Current Medicinal Chemistry Lars Petter Jordheim; Laurent Chaloin 10.2174/0929867311320340008 17
82 Astrocytes and Gliotransmitters: New Players in the Treatment of Major Depression? Current Drug Targets Adeline Etievant; Laura Lambás-Señas; H. Scarna; Guillaume Lucas; Nasser Haddjeri 10.2174/13894501113149990197 12
83 Chromosomal excision of a new pathogenicity island modulates Salmonella virulence in vivo. Current Gene Therapy Hugo E. Tobar; Franciso J. Salazar-Echegarai; Pamela A. Nieto; Christian E. Palavecino; Valentina P. Sebastián; Claudia A. Riedel; Alexis M. Kalergis; Susan M. Bueno 10.2174/1566523211313040002 7
84 The emerging role of connexin 43 in testis pathogenesis. Current Molecular Medicine Daniel Chevallier; D. Carette; Jerome Gilleron; D. Segretain; G. Pointis 10.2174/15665240113139990066 6
85 How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments Current Pharmaceutical Design Thomas Cluzeau; Guillaume Robert; Arnaud Jacquel; Patrick Auberger 10.2174/13816128113199990334 3
86 Ca(2+) fluxes involvement in gene expression during cardiac hypertrophy. Current Vascular Pharmacology Ana María Gómez; Gema Ruiz-Hurtado; Jean-Pierre Benitah; Alejandro Domínguez-Rodríguez 10.2174/1570161111311040013 29
87 Von Willebrand factor and thrombosis: risk factor, actor and pharmacological target. Current Vascular Pharmacology Peter J. Lenting; Cécile V. Denis; Nikolett Wohner 10.2174/1570161111311040008 11
88 Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity Current Molecular Medicine Pablo A. González; Leandro J. Carreño; Susan M. Bueno; Claudia A. Riedel; Alexis M. Kalergis 10.2174/1566524011313070007 11
89 Pathophysiology of NASH: perspectives for a targeted treatment. Current Pharmaceutical Design Fabio Marra; Sophie Lotersztajn 10.2174/13816128113199990344 99
90 Role of descending aminergic pathways in the development of locomotion. Current Pharmaceutical Design Edouard Pearlstein 10.2174/1381612811319240002 8
91 "It is not superstition that worries me, Herr Doctor, but genes and chromosomes" Inspector Kemp, from the movie Young Frankenstein, 1974. Current Gene Therapy Ignacio Anegon 0
92 The multiple aspects of stroke and stem cell therapy. Current Molecular Medicine Onteniente B 10.2174/1566524011313050013 12
93 Human Pluripotent Stem Cells for Modelling Human Liver Diseases and Cell Therapy Current Gene Therapy Noushin Dianat; Clara Steichen; Ludovic Vallier; Anne M. Weber; Anne Dubart-Kupperschmitt 10.2174/1566523211313020006 46
94 Editorial (hot topic: stem-cell reprogramming for medicine). Current Gene Therapy Tuan H. Nguyen 10.2174/1566523211313020001 0
95 Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series. The Open Respiratory Medicine Journal Camille Taillé; Claire Poulet; Sylvain Marchand-Adam; Raphael Borie; Marie-Christine Dombret; Bruno Crestani; Michel Aubier 10.2174/1874306401307010021 29
96 Comparative Efficacy and Safety Study of Two Chondroitin Sulfate Preparations from Different Origin (Avian and Bovine) in Symptomatic Osteoarthritis of the Knee The Open Rheumatology Journal Patrice Fardellone; Mohammed Zaim; Anne-Sophie Saurel; Emmanuel Maheu 10.2174/1874312901307010001 14
97 The need for calcium channels in cell proliferation. Recent Patents On Anti-cancer Drug Discovery Thierry Capiod 10.2174/15748928130102 51
98 Calcium channels and prostate cancer. Recent Patents On Anti-cancer Drug Discovery George Shapovalov; Roman Skryma; Natalia Prevarskaya 10.2174/15748928130103 29
99 Human Stem Cells and Articular Cartilage Tissue Engineering Current Pharmaceutical Biotechnology J.F. Stoltz; Céline Huselstein; Jessica Schiavi; Yin-Ping Li; D. Bensoussan; Véronique Decot; N. de Isla 10.2174/138920112804724846 7
100 The Tribbles-1 protein in humans: roles and functions in health and disease. Current Molecular Medicine Emilie Dugast; Endre Kiss-Toth; Jean-Paul Soulillou; Sophie Brouard; Joanna Ashton-Chess 10.2174/1566524011307010080; 10.2174/156652413804486197 15
101 Diagnosis and consequences of cocaine addiction. Current Medicinal Chemistry Laurent Karila; A. Petit; W. Lowenstein; M. Reynaud 10.2174/092986712803988839 48
102 A new model for determining the MTD during phase-I trials in pediatric oncology. Current Topics In Medicinal Chemistry Christian Faivre; D. Barbolosi; Athanassios Iliadis 10.2174/156802612803531469 2
103 Mitochondrial dysfunction and lipid homeostasis. Current Drug Metabolism Joseph Vamecq; Anne-Frédérique Dessein; Monique Fontaine; Gilbert Briand; Nicole Porchet; Norbert Latruffe; Pierre Andreolotti; Mustapha Cherkaoui-Malki 10.2174/138920012803762792 31
104 Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities? Current Topics In Medicinal Chemistry Laetitia Padovani; Carole Colin; Carla Fernandez; André Maues de Paula; Sandy Mercurio; Didier Scavarda; Frederic Frassineti; José Adélaïde; Anderson Loundou; Dominique Intagliata; Corinne Bouvier; Gabriel Lena; Daniel Birnbaum; 10.2174/156802612803531450 10
105 Pharmacogenetics of Clopidogrel Current Pharmaceutical Design Stephen A. O’Connor; Jean-Sébastien Hulot; Johanne Silvain; Guillaume Cayla; Gilles Montalescot; Jean Philippe Collet 10.2174/138161212803251880 8
106 Mitochondria As Potential Targets of Flavonoids: Focus on Adipocytes and Endothelial Cells Current Medicinal Chemistry Lucie Duluc; Raffaella Soleti; Nicolas Clere; Ramaroson Andriantsitohaina; Gilles Simard 10.2174/092986712803251467 12
107 Capsule endoscopy in Crohn's disease. Current Drug Targets Jean-Baptiste Chevaux; Gionata Fiorino; Muriel Frederic; Laurent Peyrin-Biroulet 10.2174/138945012802429732 3
108 Protein-Protein Interactions in Drug Discovery - A Leap into the Chemical Space of Protein-Protein Interaction Inhibitors Current Pharmaceutical Design Bruno O. Villoutreix; Céline M. Labbé; David Lagorce; Guillaume Laconde; Olivier Sperandio 10.2174/138161212802651571 49
109 Splicing Modulation Mediated by Small Nuclear RNAs as Therapeutic Approaches for Muscular Dystrophies Current Gene Therapy Rachid Benchaouir; Aurélie Goyenvalle 10.2174/156652312800840586 6
110 Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin. Current HIV Research Katy Janvier; Nicolas Roy; Clarisse Berlioz-Torrent 10.2174/157016212800792414 11
111 Potential anti-catabolic and anabolic properties of strontium ranelate. Current Molecular Pharmacology Romuald Mentaverri; Michel Brazier; Saïd Kamel; Patrice Fardellone 10.2174/1874467211205020189 11
112 Evaluation of Early Regenerative Processes in a Preclinical Pig Model of Acute Kidney Injury Current Molecular Medicine Ludivine Rossard; Frederic Favreau; Julie Demars; R. Robert; Cedric Nadeau; Jerome Cau; Raphael Thuillier; Thierry Hauet 10.2174/156652412800163334; 10.2174/1566524011207040502 10
113 IL-10 Producing Regulatory B Cells in Mice and Humans: State of the Art Current Molecular Medicine Jean-David Bouaziz; H. Le Buanec; Anne Saussine; Armand Bensussan; Martine Bagot 10.2174/156652412800620057 47
114 Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach Current Alzheimer Research Laetitia Troquier; Raphaëlle Caillierez; Sylvie Burnouf; Francisco J. Fernandez-Gomez; Marie-Eve Grosjean; Nadège Zommer; Nicolas Sergeant; Susanna Schraen-Maschke; David Blum; Luc Buée 10.2174/156720512800492503 148
115 Evolution of class A G-protein-coupled receptors: implications for molecular modeling. Current Medicinal Chemistry Marie Chabbert; Hélène Castel; Julien Pelé; Julie Deville; R. Legendre; Patrice Rodien 10.2174/092986712799320600 10
116 Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators Current Topics In Medicinal Chemistry Albane le Maire; Susana Álvarez; Pattabhiraman Shankaranarayanan; Angel R. de Lera; William Bourguet; Hinrich Gronemeyer 10.2174/156802612799436687 63
117 Possible Pathogenic Role of the Transmembrane Isoform of CD160 NK Lymphocyte Receptor in Paroxysmal Nocturnal Hemoglobinuria Current Molecular Medicine Jérôme Giustiniani; S. Sabour-Alaoui; J. Bernard; Daniel Olive; C. Bos; A. Razafindratsita; Anna D. Petropoulou; R.P. de Latour; P. Le Bouteiller; Martine Bagot; Gérard Socié; Armand Bensussan; Aude Marie-Cardine 10.2174/156652412798889081 3
118 ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction. Current Molecular Medicine Santiago Zalvidea; Lucas Andre; Xavier Loyer; Cécile Cassan; Yannis Sainte-Marie; Jérôme Thireau; Ivar Sjaastad; Christophe Heymes; Jean-Luc Pasquié; Olivier Cazorla; Franck Aimond; Sylvain Richard 10.2174/156652412798889045 11
119 Potential anticancer properties of bisphosphonates: insights from preclinical studies. Anti-cancer Agents In Medicinal Chemistry Philippe Clézardin 10.2174/187152012799014977 26
120 The family B1 GPCR: structural aspects and interaction with accessory proteins. Current Drug Targets Alain Couvineau; Marc Laburthe 10.2174/138945012798868434 32
121 Basal breast cancer: a complex and deadly molecular subtype. Current Molecular Medicine François Bertucci; P. Finetti; Daniel Birnbaum 10.2174/156652412798376134 131
122 Structure and modeling of knottins, a promising molecular scaffold for drug discovery. Current Pharmaceutical Design Jérôme Gracy; Laurent Chiche 10.2174/138161211798999339 23
123 Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis Current Genomics Alexandre Henriques; Jose-Luis Gonzalez de Aguilar 10.2174/138920211797904043 15
124 Regulation of autophagy by sphingolipids. Anti-cancer Agents In Medicinal Chemistry Carmen Bedia; Thierry Levade; Patrice Codogno 10.2174/187152011797655131 43
125 Chemical Connexin Impairment in the Developing Gonad Associated with Offspring Infertility Current Medicinal Chemistry Jerome Gilleron; A. Malassine; D. Carette; D. Segretain; Georges Pointis 10.2174/092986711797636117 7
126 Active-targeted nanotherapy strategies for prostate cancer. Current Cancer Drug Targets M. Katsogiannou; Ling Peng; C. V. Catapano; P. Rocchi 10.2174/156800911797264770 15
127 Therapeutic Potential of Peptide Toxins that Target Ion Channels Inflammation & Allergy Drug Targets Beraud E; Chandy Kg 10.2174/187152811797200696 16
128 Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion. Recent Patents On Anti-cancer Drug Discovery Sarah Shirley; Alexandre Morizot; Olivier Micheau 10.2174/157489211796957757 53
129 Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions Cardiovascular & Hematological Disorders Drug Targets Esma R. Isenovic; Sanja Soskic; Hans-Dirk Dungen; Branislava Dobutovic; Tahirovic Elvis; Inkrot Simone; Pierre Marche 10.2174/187152911798346972 13
130 Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Patents On Anti-cancer Drug Discovery Elodie Lafont; Kazuyuki Kitatani; Toshiro Okazaki; Bruno Ségui 10.2174/157489211796957801 8
131 Kinins as Therapeutic Agents in Cardiovascular and Renal Diseases Current Pharmaceutical Design François Alhenc-Gelas; Nadine Bouby; Christine Richer; Louis Potier; Ronan Roussel; Michel Marre 10.2174/138161211797416002 19
132 Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype Current Alzheimer Research Pascale Barberger-Gateau; Cécilia Samieri; Catherine Féart; Mélanie Plourde 10.2174/156720511796391926 91
133 The role of the urokinase receptor in epilepsy, in disorders of language, cognition, communication and behavior, and in the central nervous system. Current Pharmaceutical Design Nadine Bruneau; Pierre Szepetowski 10.2174/138161211796718198 24
134 Pharmacological Treatments of Opiate Dependence Current Pharmaceutical Design Amine Benyamina; Michel Reynaud; Lisa Blecha; Laurent Karila 10.2174/138161211796150855 5
135 Effects of nutrients on postprandial lipemia. Current Vascular Pharmacology Denis Lairon; Catherine Defoort 10.2174/157016111795495576 22
136 Pharmacotherapy for smoking cessation: present and future. Current Pharmaceutical Design Henri-Jean Aubin; Laurent Karila; Michel Reynaud 10.2174/138161211796150837 31
137 Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide The Open Virology Journal Laetitia Carthagena; Pierre Becquart; Hakim Hocini; Michel D. Kazatchkine; Hicham Bouhlal; Laurent Bélec 10.2174/1874357901105010027 10
138 Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice. Drug Metabolism Letters Minh Hien Pham; Hervé Rhinn; Nicolas Auzeil; Anne Regazzetti; Djamel Eddine Harami; Daniel Scherman; Guy G. Chabot 10.2174/187231211795305221 3
139 VIP-induced neuroprotection of the developing brain Current Pharmaceutical Design Sandrine Passemard; Paulina Sokolowska; Leslie Schwendimann; Pierre Gressens 10.2174/138161211795589409 22
140 Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Current Medicinal Chemistry Dominique Delmas; Eric Solary; Norbert Latruffe 10.2174/092986711795029708 124
141 EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study. Current Alzheimer Research Bruno Vellas; Olivier Sol; Peter J. Snyder; Pierre-Jean Ousset; Raphael Haddad; Mylene Maurin; Jean-Christophe Lemarie; Laurent Desire; Matthew P. Pando 10.2174/156720511795256053 80
142 Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations Current Pharmaceutical Design Martine Caron-Debarle; Franck Boccara; Claire Lagathu; Bénédicte Antoine; Pascale Cervera; Jean-Philippe Bastard; Corinne Vigouroux; Jacqueline Capeau 10.2174/138161210793563446 33
143 Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments. Current Drug Targets Luc Dupuis; Andoni Echaniz-Laguna 10.2174/1389450111007011250 35
144 Assessment of Bishosphonate Activity In Vitro Current Pharmaceutical Design L. Mitrofan; Seppo Auriola; H. Monkkonen; Jukka Monkkonen 10.2174/138161210793563644 2
145 Therapeutic Approach of Primary Bone Tumours by Bisphosphonates Current Pharmaceutical Design Gatien Moriceau; Benjamin Ory; Bérengère Gobin; Franck Verrecchia; François Gouin; Frédéric Blanchard; Françoise Rédini; Dominique Heymann 10.2174/138161210793563554 36
146 Alternative Use of Bisphosphonate Therapy for Rheumatic Disease Current Pharmaceutical Design B. Le Goff; Jean-Marie Berthelot; Yves Maugars; Evange Romas 10.2174/138161210793563626 14
147 A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis Current Pharmaceutical Design B. Le Goff; P. Guillo; Joëlle Glémarec; J.-M. Berthelot; Yves Maugars 10.2174/138161210793563563 8
148 Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies. Current Drug Targets Aude-Hélène Capietto; Samarh Keirallah; Emilie Gross; Nicolas Dauguet; Emilie Laprevotte; Christine Jean; Julie Gertner-Dardenne; Christine Bezombes; Anne Quillet-Mary; Mary Poupot; Loic Ysebaert; Guy Laurent; Jean-Jacques Fournié 10.2174/138945010791320845 8
149 Vascular and endothelial regeneration. Current Stem Cell Research & Therapy Louis Casteilla; Valérie Planat-Benard; Béatrice Cousin; Patrick Laharrague; Philippe Bourin 10.2174/157488810791268546 16
150 Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort. Current HIV Research Gaëlle Encrenaz; Antoine Bénard; Virginie Rondeau; Fabrice Bonnet; Estibaliz Lazaro; Didier Neau; Michel Dupon; François Dabis; Patrick Mercié; Geneviève Chêne 10.2174/157016210791111089 10
151 Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms. Current Medicinal Chemistry Ulinski T; Aoun B 10.2174/092986710790712174 15
152 Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue. The Open Rheumatology Journal Jean-Marc Brondello; Didier Philipot; Farida Djouad; Christian Jorgensen; Danièle Noël 10.2174/1874312901004010010 9
153 Interaction and structural modification of topoisomerase IIα by peptidyl prolyl isomerase, pin1: An In Silico study Protein And Peptide Letters Rohit Mathur; Shubhanker Suman; Nicolas Beaume; Mashook Ali; Anant Narayan Bhatt; Madhu Chopra; Daman Saluja; Anil K. Mishra; Sudhir Chandna; Pramesh N. Kapoor; Bilikere S. Dwarakanath 10.2174/092986610790226030 2
154 Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review. Current Drug Targets Abderrahim Oussalah; Silvio Danese; Laurent Peyrin-Biroulet 10.2174/138945010790309939 41
155 Redistribution of CD95 into the lipid rafts to treat cancer cells Recent Patents On Anti-cancer Drug Discovery Bruno Ségui; Patrick Legembre 10.2174/157489210789702190 15
156 Structure-Based Virtual Ligand Screening: Recent Success Stories Combinatorial Chemistry & High Throughput Screening Bruno O. Villoutreix; Richard Eudes; Maria A. Miteva 10.2174/138620709789824682 108
157 Cartilage Tissue Engineering: Towards a Biomaterial-Assisted Mesenchymal Stem Cell Therapy Current Stem Cell Research & Therapy Claire Vinatier; Carine Bouffi; Christophe Merceron; Jan O. Gordeladze; Jean-Marc Brondello; Christian Jorgensen; Pierre Weiss; Jérôme Guicheux; Danièle Noël 10.2174/157488809789649205 171
158 Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection Current Medicinal Chemistry Didier Morin; Rana Assaly; Stéphanie Paradis; Alain Berdeaux 10.2174/092986709789712871 56
159 Angiotensin, the hormone to be blocked by antithypertensive drugs, and perhaps why they don't work. Current Vascular Pharmacology Simon N. Thornton 10.2174/157016109789043874 3
160 Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting. Current Molecular Medicine Christine Pasero; Alemseged Truneh; Daniel Olive 10.2174/156652409789105589 14
161 Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis. Current Genomics Christophe Bureau; Naïma Hanoun; Jérôme Torrisani; Jean-Pierre Vinel; Louis Buscail; Pierre Cordelier 10.2174/138920209788921010 61
162 How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort. Current HIV Research Patrick Peretti-Watel; Virginie Villes; Xavier Duval; Fidéline Collin; Jacques Reynes; Alain Sobel; Camelia Protopopescu; Geneviève Chêne; Bruno Spire; François Raffi 10.2174/157016209788680624 8
163 Neutrophil apoptosis during viral infections. The Open Virology Journal Carole Elbim; Peter D. Katsikis; Jérôme Estaquier 10.2174/1874357900903010052 22
164 Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer. Anti-cancer Agents In Medicinal Chemistry Olivier Peyruchaud 10.2174/1871520610909040381 20
165 In Vivo Localization of Fas-Associated Death Domain Protein in the Nucleus and Cytoplasm of Normal Thyroid and Liver Cells The Open Autoimmunity Journal Léa Tourneur; Alain Schmitt; Gilles Chiocchia 10.2174/1876894600901010027 2
166 Pre-Clinical and Clinical Evaluation of Nuclear Tracers for the Molecular Imaging of Vulnerable Atherosclerosis: An Overview Current Medicinal Chemistry Laurent Riou; Alexis Broisat; Julien Dimastromatteo; Guillaume Pons; Daniel Fagret; Catherine Ghezzi 10.2174/092986709787909596 21
167 Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors. Current Gene Therapy Tuan Huy Nguyen; Sylvie Mainot; Panagiotis Lainas; Marie-Thérèse Groyer-Picard; Dominique Franco; Ibrahim Dagher; Anne M. Weber 10.2174/156652309787909481 29
168 Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. Current Alzheimer Research Karim Belarbi; Katharina Schindowski; Sylvie Burnouf; Raphaëlle Caillierez; Marie-Eve Grosjean; Dominique Demeyer; Malika Hamdane; Nicolas Sergeant; David Blum; Luc Buée 10.2174/156720509787602843 38
169 Current Screens Based on the AlphaScreen™ Technology for Deciphering Cell Signalling Pathways Current Genomics Saïd Taouji; Sophie Dahan; Roger Bossé; Eric Chevet 10.2174/138920209787847041 41
170 Renal Protective Effect of Metabolic Therapy in Patients with Coronary Artery Disease and Diabetes : From Bench to Bed Side Current Pharmaceutical Design Raphael Thuillier; Jean Paul Tillement; Thierry Hauet 10.2174/138161209787582110 4
171 Structure-function relationship of Vpr: biological implications. Current HIV Research Nelly Morellet; Bernard P. Roques; Serge Bouaziz 10.2174/157016209787581490 38
172 Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models. Infectious Disorders Drug Targets Cécile Voisset; Sven J. Saupe; Hervé Galons; Marc Blondel 10.2174/1871526510909010031 9
173 Multivalent-Based Drug Design Applied to Serotonin 5-HT4 Receptor Oligomers Current Pharmaceutical Design Frank Lezoualc'h; Ralf Jockers; Isabelle Berque-Bestel 10.2174/138161209787315602 13
174 The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors. Recent Patents On Anti-cancer Drug Discovery Rachid Lahlil; Fabien Calvo; Abdel-Majid Khatib 10.2174/157489209787002470 9
175 Strategies for Targeting Lentiviral Vectors Current Gene Therapy Cecilia Frecha; Judit Szécsi; François-Loïc Cosset; Els Verhoeyen 10.2174/156652308786848003 68
176 Proliferation of Breast Cancer Cells: Regulation, Mediators, Targets for Therapy Anti-cancer Agents In Medicinal Chemistry Mester J; Redeuilh G 10.2174/187152008786847747 23
177 CDC25A: a rebel within the CDC25 phosphatases family? Anti-cancer Agents In Medicinal Chemistry Anne Fernandez-Vidal; Anne Mazars; Stéphane Manenti 10.2174/187152008786847684 32
178 Bivalent Ligands as Specific Pharmacological Tools for G Protein-Coupled Receptor Dimers Current Drug Discovery Technologies Isabelle Berque-Bestel; Frank Lezoualc'h; Ralf Jockers 10.2174/157016308786733591 54
179 Metabolic Effects of Resveratrol in Mammals - a Link Between Improved Insulin Action and Aging Current Aging Science Sara Fröjdö; Christine Durand; Luciano Pirola 10.2174/1874609810801030145 36
180 PPARgamma and early human placental development. Current Medicinal Chemistry Thierry Fournier; Patrice Therond; Karen Handschuh; Vassilis Tsatsaris; Danièle Evain-Brion 10.2174/092986708786848677 32
181 Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption Recent Patents On Anti-cancer Drug Discovery Brounais Benedicte; Ruiz V. Carmen; Rousseau Julie; Lamoureux Francois; Blanchard Frederic; Heymann Dominique; Redini Francoise 10.2174/157489208786242269 7
182 Chemokine network in the nervous system: a new target for pain relief. Current Medicinal Chemistry Romain-Daniel Gosselin; Marc-André Dansereau; Michel Pohl; Patrick Kitabgi; Nicolas Beaudet; Philippe Sarret; S. Melik Parsadaniantz 10.2174/092986708786242822 58
183 The genetic basis of sleep disorders. Current Pharmaceutical Design Yves Dauvilliers; Mehdi Tafti 10.2174/138161208786549308 20
184 Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect. Medicinal Chemistry (Shariqah (United Arab Emirates)) Khadija Ouguerram; Yassine Zair; Stephanie Billon; Maud Chétiveaux; Cécile Brunet-François; Kalyane Ngohou-Bach; Clotilde Allavena; Véronique Reliquet; Brigitte Milpied; T. Magot 10.2174/157340608786242061 2
185 From Cochlear Cell Death Pathways To New Pharmacological Therapies Mini Reviews In Medicinal Chemistry Jing Wang; Jean-Luc Puel 10.2174/138955708785740599 7
186 Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Current Pharmaceutical Design J.L. Guéant; Rosa-Maria Guéant-Rodriguez; I. Aimone Gastin; Jose A. Cornejo-Garcia; Marinella Viola; Annick Barbaud; Paul-Michel Mertes; M. Blanca; Antonino Romano 10.2174/138161208786369795 33
187 Recent advances in the characterization of genetic factors involved in human susceptibility to infection by schistosomiasis. Current Genomics Amandine Isnard; Christophe Chevillard 10.2174/138920208785133262 10
188 GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data Current Alzheimer Research Sandrine Andrieu; Pierre-Jean Ousset; Nicola Coley; Mehemed Ouzid; Hélène Mathiex-Fortunet; Bruno Vellas 10.2174/156720508785132271 48
189 Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis. Current Pharmaceutical Design Franck Pellestor; Petra Paulasova; Samir Hamamah 10.2174/138161208785777405 31
190 Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases. Current Medicinal Chemistry Andoni Echaniz-Laguna; O. Bousiges; J.-P. Loeffler; A.-L. Boutillier 10.2174/092986708784534974 37
191 Dihydropyridine receptor blockade in the treatment of asthma. Recent Patents On Inflammation & Allergy Drug Discovery Lucette Pelletier; Jean-Charles Guéry 10.2174/187221308784543638 8
192 Erythropoietic porphyrias: animal models and update in gene-based therapies. Current Gene Therapy Emmanuel Richard; Elodie Robert-Richard; Cécile Ged; François Moreau-Gaudry; Hubert de Verneuil 10.2174/156652308784746477 25
193 Alkylsquarates as Key Intermediates for the Rapid Preparation of Original Drug-Inspired Compounds Combinatorial Chemistry & High Throughput Screening Julie Charton; Lise Charruault; Rebecca Deprez-Poulain; Benoit Deprez 10.2174/138620708784246013 7
194 In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics. Current Pharmaceutical Biotechnology Bruno O. Villoutreix; Karine Bastard; Olivier Sperandio; Robin Fåhraeus; Jean-Luc Poyet; Fabien Calvo; Benoit Deprez; Maria A. Miteva 10.2174/138920108783955218 47
195 Inhibitory Feature of the Proprotein Convertases Prosegments Medicinal Chemistry (Shariqah (United Arab Emirates)) Yannick Bontemps; Marion Lapierre; Geraldine Siegfried; Fabien Calvo; Abdel-Majid Khatib 10.2174/157340608783789176 6
196 To Die or Not to Die: That is the Autophagic Question Current Molecular Medicine Lorenzo Galluzzi; Jose Miguel Vicencio; Oliver Kepp; Ezgi Tasdemir; Maria Chiara Maiuri; Guido Kroemer 10.2174/156652408783769616 229
197 Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART). The Open AIDS Journal Marguerite Guiguet; Kholoud Porter; Andrew N. Phillips; Dominique Costagliola; Abdel Babiker 10.2174/1874613600802010003 13
198 Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. Current HIV Research Miriam Lichtner; Raffaella Rossi; M.C. Rizza; Fabio Mengoni; Ilaria Sauzullo; Anna Paola Massetti; Giuseppe Luzi; Anne Hosmalin; Claudio Maria Mastroianni; Vincenzo Vullo 10.2174/157016208783571937 24
199 Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Current Stem Cell Research & Therapy Vanessa Fritz; Christian Jorgensen 10.2174/157488808783489462 76
200 Mannose 6-phosphate receptor targeting and its applications in human diseases. Current Medicinal Chemistry Magali Gary-Bobo; Philippe Nirdé; Audrey Jeanjean; Alaih Morère; Marcel Garcia 10.2174/092986707782794005 102
201 Cytokines as Regulators of Atherosclerosis in Murine Models Current Drug Targets Ziad Mallat; Alain Tedgui 10.2174/138945007783220588 12
202 Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Current Medicinal Chemistry Celine Didelot; David Lanneau; M. Brunet; Anne-Laure Joly; Aurélie de Thonel; Gabriela Chiosis; Carmen Garrido 10.2174/092986707782360079 115
203 Myostatin in the pathophysiology of skeletal muscle. Current Genomics Gilles Carnac; Barbara Vernus; Anne Bonnieu 10.2174/138920207783591672 31
204 Multiligand endocytosis and congenital defects: roles of cubilin, megalin and amnionless. Current Pharmaceutical Design Renata Kozyraki; Françoise Gofflot 10.2174/138161207782110507 38
205 Antipsychotics dosage and antiparkinsonian prescriptions. Clinical Practice And Epidemiology In Mental Health : CP & EMH Eric Acquaviva; Isabelle Gasquet; Bruno Falissard 10.1186/1745-0179-3-14 4
206 Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis. Current Medicinal Chemistry Georges Pointis; C. Fiorini; Jerome Gilleron; D. Carette; D. Segretain 10.2174/092986707781696564 60
207 Free Resources to Assist Structure-Based Virtual Ligand Screening Experiments Current Protein & Peptide Science Bruno O. Villoutreix; Nicolas Renault; David Lagorce; Olivier Sperandio; Matthieu Montes; Maria A. Miteva 10.2174/138920307781369391 97
208 Analgesia induced by morphine microinjected into the nucleus raphe magnus: effects on tonic pain. Current Drug Delivery Christian Dualé; Fernando Sierralta; Radhouane Dallel 10.2174/156720107781023884 12
209 Potential of recombinant SV40-based vectors for gene therapy. Recent Patents On DNA & Gene Sequences Louis Buscail; Pierre Cordelier 10.2174/187221507780887045 2
210 mTOR Inhibitors (Rapamycin and its Derivatives) and Nitrogen Containing Bisphosphonates: Bi-Functional Compounds for the Treatment of Bone Tumours Current Medicinal Chemistry Benjamin Ory; Gatien Moriceau; Françoise Rédini; Dominique Heymann 10.2174/092986707780831159 26
211 Enjoy the Silence: The Story of let-7 MicroRNA and Cancer. Current Genomics Torrisani Jérôme; Parmentier Laurie; Buscail Louis; Cordelier Pierre 10.2174/138920207781386933 70
212 Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues. Current Gene Therapy Therese Cronin; Thierry Léveillard; José-Alain Sahel 10.2174/156652307780363143 29
213 Recent developments in tumor angiogenesis. Current Pharmaceutical Biotechnology Witold W. Kilarski; Andreas Bikfalvi 10.2174/138920107779941444 16
214 Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algae. Cardiovascular & Hematological Agents In Medicinal Chemistry Catherine Boisson-Vidal; Faouzia Zemani; G. Caligiuri; Isabelle Galy-Fauroux; Sylvia Colliec-Jouault; D. Helley; Anne-Marie Fischer 10.2174/187152507779315778 36
215 Genetic variation of human adrenergic receptors: from molecular and functional properties to clinical and pharmacogenetic implications. Current Topics In Medicinal Chemistry Stéphane Schaak; Jeanne Mialet-Perez; Christodoulos S. Flordellis; Hervé Paris 10.2174/156802607779318163 19
216 Interest of α2-Adrenergic Agonists and Antagonists in Clinical Practice: Background, Facts and Perspectives Current Topics In Medicinal Chemistry Pierre-Antoine Crassous; Colette Denis; Hervé Paris; Jean-Michel Senard 10.2174/156802607779318190 55
217 Voltage-gated sodium channels: new targets in cancer therapy? Current Pharmaceutical Design Sébastien Roger; Marie Potier; Christophe Vandier; Pierre Besson; Jean-Yves Le Guennec 10.2174/138161206778522047 68
218 Electrotransfer into skeletal muscle for protein expression. Current Gene Therapy Capucine Trollet; Carole Bloquel; Daniel Scherman; Pascal Bigey 10.2174/156652306778520656 64
219 Receptor-Based Computational Screening of Compound Databases: The Main Docking-Scoring Engines Current Protein & Peptide Science Olivier Sperandio; Maria A. Miteva; François Delfaud; Bruno O. Villoutreix 10.2174/138920306778559377 48
220 Hypersensitivity Reactions to Iodinated Contrast Media Current Pharmaceutical Design Rosa-Maria Guéant-Rodriguez; Antonino Romano; Annick Barbaud; Knut Brockow; Jean-Louis Guéant 10.2174/138161206778193999 43
221 IgE-Mediated Hypersensitivity to Cephalosporins Current Pharmaceutical Design Jean-Louis Guéant; Rosa-Maria Guéant-Rodriguez; Marinella Viola; Rocco Luigi Valluzzi; Antonino Romano 10.2174/138161206778194060 29
222 Drug hypersensitivity: epidemiology and risk factors. Current Pharmaceutical Design Laurence Guglielmi; P. Guglielmi; Pascal Demoly 10.2174/138161206778194088 23
223 Kinins and cardiovascular diseases. Current Pharmaceutical Design Jin Bo Su 10.2174/138161206778194051 27
224 Role of ABC transporters in the chemoresistance of human gliomas. Current Cancer Drug Targets Xavier Declèves; Alexandra Benouaich Amiel; Jean-Yves Delattre; Jean-Michel Scherrmann 10.2174/156800906777723930 56
225 Development, validation, and applications of anisotropic polarizable molecular mechanics to study ligand and drug-receptor interactions. Current Pharmaceutical Design Nohad Gresh 10.2174/138161206777585256 24
226 Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias. Current Pharmaceutical Biotechnology Laure Deville; Josette Hillion; Michel Lanotte; Philippe Rousselot; Evelyne Ségal-Bendirdjian 10.2174/138920106777549768 13
227 Ligand binding domain of vitamin D receptors. Current Topics In Medicinal Chemistry Natacha Rochel; Dino Moras 10.2174/156802606777864926 34
228 Ultrasonic Elasticity Imaging as a Tool for Breast Cancer Diagnosis and Research Current Medical Imaging Reviews C. Pellot-Barakat; Mallika Sridhar; Karen K. Lindfors; Michael F. Insana 10.2174/157340506775541631 29
229 The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS & Neurological Disorders Drug Targets Ludovic Leriche; Erwan Bezard; C.E. Gross; Olivier Guillin; Bernard Le Foll; Jorge Diaz; Pierre Sokoloff 10.2174/187152706784111551 277
230 Matrix metalloproteinases: a potential therapeutic target in atherosclerosis. Current Drug Targets. Cardiovascular & Haematological Disorders Mustapha Rouis 10.2174/156800605774961979 24
231 Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives Current Pharmaceutical Design Stéphane Burlet; Nicolas Pietrancosta; Younes Laras; Cédrik Garino; Gilles Quéléver; Jean-Louis Kraus 10.2174/1381612054864939 9
232 The Key Role of Medullary 5-HT3 Receptors in the Serotonin-Mediated Neural Control of Cardiovascular Function. Current Neuropharmacology Caroline Sévoz-Couche; B. H. Machado; Martial Hamon; Raul Laguzzi 10.2174/1570159054368277 1
233 Helper functions required for wild type and recombinant adeno-associated virus growth. Current Gene Therapy Marie-Claude Geoffroy; Anna Salvetti 10.2174/1566523054064977 58
234 Chemokines and brain functions. Current Drug Targets. Inflammation And Allergy Ghazal Banisadr; William Rostène; Patrick Kitabgi; Stéphane Melik Parsadaniantz 10.2174/1568010054022097 78
235 Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer. Current Pharmaceutical Design E. Paulhe; Stéphane Manenti; Loic Ysebaert; R. Betous; P. Sultan; Claire Racaud-Sultan 10.2174/1381612054065765 16
236 Voltage Gated Calcium Channels as Targets for Analgesics Current Topics In Medicinal Chemistry Emmanuel Bourinet; Gerald W. Zamponi 10.2174/1568026054367610 39
237 Hepcidin in iron metabolism. Current Protein & Peptide Science Olivier Loréal; Christelle Haziza-Pigeon; Marie-Bérengère Troadec; Lénaïck Détivaud; Bruno Turlin; Brice Courselaud; Guennadi Ilyin; Pierre Brissot 10.2174/1389203054065392 47
238 Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach. Current Drug Targets V. M. Tatard; Philippe Menei; Jean-Pierre Benoit; Claudia N. Montero-Menei 10.2174/1389450053344885 33
239 Chemoresistance in non-small cell lung cancer. Current Medicinal Chemistry. Anti-cancer Agents Pascal Sève; Charles Dumontet 10.2174/1568011053352604 124
240 Cellular and Molecular Effects of Macrolides on Leukocyte Function Current Pharmaceutical Design Marie-Thérèse Labro 10.2174/1381612043383403 27
241 Neprilysin 2: a novel messenger peptide-inactivating metalloprotease. Protein And Peptide Letters Tanja Ouimet 10.2174/0929866043406625 4
242 Cancer gene therapy through autonomous parvovirus--mediated gene transfer. Current Gene Therapy Jan Cornelis; Susanne I. Lang; Alexandra Stroh-Dege; Ginette Balboni; Christiane Dinsart; Jean Rommelaere 10.2174/1566523043346228 33
243 Tumor cell resistance to DNA-damaging agents: from apoptosis to neiosis. Current Medicinal Chemistry. Anti-cancer Agents François Martin; Eric Solary 10.2174/1568011043352768 8
244 Growth Factors and Bone Formation in Osteoporosis: Roles for Fibroblast Growth Factor and Transforming Growth Factor Beta Current Pharmaceutical Design Olivia Fromigué; Dominique Modrowski; Pierre J. Marie 10.2174/1381612043383773 50
245 Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids. Current Medicinal Chemistry. Anti-cancer Agents Christian Bailly 10.2174/1568011043352939 172
246 Design of novel antitumor DNA alkylating agents: the benzacronycine series. Current Medicinal Chemistry. Anti-cancer Agents Marie-Hélène David-Cordonnier; William Laine; Thomas Gaslonde; Sylvie Michel; François Tillequin; Michel H. J. Koch; Stéphane Léonce; Alain Pierre; Christian Bailly 10.2174/1568011043482115 14
247 Animal models of HLA-B27-associated diseases. Current Molecular Medicine Maxime Breban; Cécile Hacquard-Bouder; Géraldine Falgarone 10.2174/1566524043479347 48
248 5-HT1 receptors. Current Drug Targets. CNS And Neurological Disorders Laurence Lanfumey; Michel Hamon 10.2174/1568007043482570 135
249 5-HT4 receptors. Current Drug Targets. CNS And Neurological Disorders Joël Bockaert; Sylvie Claeysen; Valérie Compan; Aline Dumuis 10.2174/1568007043482615 167
250 Revisiting Pitfalls, Problems and Tentative Solutions for Assaying [General Articles] Mitochondrial Respiratory Chain Complex III in Human Samples Current Medicinal Chemistry Dominique Chretien; Abdelhamid Slama; Jean-Jacques Brière; Arnold Munnich; Agnès Rötig; Pierre Rustin 10.2174/0929867043456151 27
251 Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Current Drug Targets Nikolaus Seiler 10.2174/1389450033490876 97
252 Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors Current Drug Targets Nikolaus Seiler 10.2174/1389450033490885 151
253 New antiviral nucleoside prodrugs await application. Current Medicinal Chemistry Carole Anastasi; Gilles Quéléver; Stéphane Burlet; Cédrik Garino; Florence Souard; Jean-Louis Kraus 10.2174/0929867033457034 28
254 Drug resistance to cytotoxic nucleoside analogues. Current Drug Targets Lars Petter Jordheim; Carlos M. Galmarini; Charles Dumontet 10.2174/1389450033490957 34
255 Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells. Current Medicinal Chemistry. Anti-cancer Agents Ali Bettaieb; Laurence Dubrez-Daloz; Sophie Launay; Stéphanie Plenchette; Cédric Rébé; Séverine Cathelin; Eric Solary 10.2174/1568011033482396 32
256 Gab1, SHP-2 and Other Novel Regulators of Ras: Targets for Anticancer Drug Discovery? Current Cancer Drug Targets Armelle Yart; Patrick Mayeux; Patrick Raynal 10.2174/1568009033481976 26
257 Gene therapy of chronic pain. Current Gene Therapy Michel Pohl; Alice Meunier; Michel Hamon; Joao M. Braz 10.2174/1566523034578348 26
258 Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Current Medicinal Chemistry. Anti-cancer Agents S Shinkaruk; M. Bayle; G. Lain; Gérard Déléris 10.2174/1568011033353452 182
259 Nucleic acids as targets for antitelomerase agents. Mini Reviews In Medicinal Chemistry Patrizia Alberti; Laurent Lacroix; Lionel Guittat; Claude Hélène; Jean-Louis Mergny 10.2174/1389557033405485 22
260 Retinoic acid metabolism and mechanism of action: a review. Current Drug Metabolism Julie Marill; Nadia Idres; Claude Capron; Eric Nguyen; Guy G. Chabot 10.2174/1389200033336900 184
261 In vitro and in vivo antitumor effects of bisphosphonates. Current Medicinal Chemistry Philippe Clézardin; Pierrick G.J. Fournier; Sandrine Boissier; Olivier Peyruchaud 10.2174/0929867033368529 73
262 Dendritic cells in innate immune responses against HIV. Current Molecular Medicine C. Servet; Laurence Zitvogel; Anne Hosmalin 10.2174/1566524023361907 54
263 Unusual DNA conformations: implications for telomeres. Current Medicinal Chemistry. Anti-cancer Agents Martin Mills; Laurent Lacroix; Paola B. Arimondo; Jean-Louis Leroy; Jean-Christophe François; Horst H. Klump; Jean-Louis Mergny 10.2174/1568011023353877 44
264 Heterotrimeric G proteins control diverse pathways of transmembrane signaling, a base for drug discovery. Mini Reviews In Medicinal Chemistry Yves Landry; J.-P. Gies 10.2174/1389557023405945 28
265 Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Current Pharmaceutical Design Cheraz Khelifi Younes; Raphaël Boisgard; Bertrand Tavitian 10.2174/1381612023394467 68
266 Structural bioinformatics: methods, concepts and applications to blood coagulation proteins. Current Protein & Peptide Science Bruno O. Villoutreix 10.2174/1389203023380657 15
267 Driving in vitro selection of anti-HIV-1 TAR aptamers by magnesium concentration and temperature. Combinatorial Chemistry & High Throughput Screening Fabien Darfeuille; D. Sekkai; Eric Dausse; Gaëlle Kolb; L. Yurchenko; Claudine Boiziau; Jean-Jacques Toulmé 10.2174/1386207023330282 12
268 Leech thrombin inhibitors. Current Pharmaceutical Design Michel Salzet 10.2174/1381612023395664 45
269 Genetic engineering in allotransplantation of vascularized organs. Current Gene Therapy Patrick Mathieu; Christine Chauveau; D Bouchet; C. Guillot; Laurent Tesson; Ignacio Anegon 10.2174/1566523023348147 5
270 Progress in Gene Delivery by Cationic Lipids : Guanidinium-Cholesterol-Based Systems as an Example Current Drug Targets Abderrahim Aissaoui; Noufissa Oudrhiri; Laure Petit; Michelle Hauchecorne; Erwan Kan; Matthieu Sainlos; Sebastien Julia; Jean Navarro; Jean-Pierre Vigneron; Jean-Marie Lehn 10.2174/1389450023348082 49
271 Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences. Current Medicinal Chemistry. Anti-cancer Agents Paola B. Arimondo; Hélène C 10.2174/1568011013354642 17
272 Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities. Current Drug Targets. Immune, Endocrine And Metabolic Disorders P. Lefebvre 10.2174/1568008013341389; 10.2174/1568005310101020153 27
273 Chemokine receptors as anti-retroviral targets. Current Drug Targets Nicolaus Heveker 10.2174/1389450013348849 9
274 Dosimetry and Microdosimetry of Targeted Radiotherapy Current Pharmaceutical Design Manuel Bardiès; Pascal Pihet 10.2174/1381612003399176 29
275 Ornithine aminotransferase, a potential target for the treatment of hyperammonemias. Current Drug Targets Nikolaus Seiler 10.2174/1389450003349254 39
276 Design and Evaluation of Hepatitis B Virus Inhibitors Current Pharmaceutical Design Olivier Hantz; Jean-Louis Kraus; Fabien Zoulim 10.2174/1381612003400740 6
277 Topoisomerase I Poisons and Suppressors as Anticancer Drugs Current Medicinal Chemistry Christian Bailly 10.2174/0929867003375489 216
Webmaster Contact: info@benthamscience.net
Copyright © 2020 Bentham Science